Close Menu

NEW YORK (GenomeWeb) – Biocept said today that it has signed a provider agreement with Alliance Global to market and distribute its Target Selector liquid biopsy tests in the United Arab Emirates, as well as select countries in the Middle East, North and Sub-Saharan Africa, and Southeast Asia region.

Under the agreement, Biocept will perform all diagnostic testing services in its San Diego CLIA-certified laboratory. Alliance Global will be responsible for sales, marketing, distribution, and reimbursement. Additional terms of the agreement were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Matt Hancock, the UK health secretary, is calling for the swift rollout of predictive genetic tests, the Guardian reports.

A WHO panel is calling for a global registry of human germline gene-editing projects, according to Stat News.

Vox writes that lab mishaps involving pathogens are quite common.

In Genome Biology this week: analysis of wild and cultivated peach genomes, Hi-C-based pipeline for assembling microbial genomes from metagenomic data, and more.